208 related articles for article (PubMed ID: 32242549)
1. [Lipid lowering treatment of severe hypertriglyceridemia with acute pancreatitis caused by everolimus in a patient with a neuroendocrine tumor].
De Carlos Artajo J; Castro Unanua N; Muruzábal Huarte E; Vera García R; Irigaray Echarri A; Zubiría Gortázar J; Anda Apiñániz E
An Sist Sanit Navar; 2020 Apr; 43(1):103-106. PubMed ID: 32242549
[TBL] [Abstract][Full Text] [Related]
2. Everolimus causing severe hypertriglyceridemia and acute pancreatitis.
Subramaniam S; Zell JA; Kunz PL
J Natl Compr Canc Netw; 2013 Jan; 11(1):5-9. PubMed ID: 23307976
[TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering therapy of everolimus-related severe hypertriglyceridaemia in a pancreatic neuroendocrine tumour (pNET).
De Gennaro Colonna V; Pavanello C; Rusconi F; Sartore-Bianchi A; Siena S; Castelnuovo S; Sirtori CR; Mombelli G
J Clin Pharm Ther; 2018 Feb; 43(1):114-116. PubMed ID: 28730672
[TBL] [Abstract][Full Text] [Related]
4. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.
Christian JB; Arondekar B; Buysman EK; Jacobson TA; Snipes RG; Horwitz RI
Am J Med; 2014 Jan; 127(1):36-44.e1. PubMed ID: 24384100
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature.
Faggiano A; Malandrino P; Modica R; Agrimi D; Aversano M; Bassi V; Giordano EA; Guarnotta V; Logoluso FA; Messina E; Nicastro V; Nuzzo V; Sciaraffia M; Colao A
Oncologist; 2016 Jul; 21(7):875-86. PubMed ID: 27053503
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan.
Liu CT; Chen MH; Chen JS; Chen LT; Shan YS; Lu CH; Su YL; Ku FC; Chou WC; Chen YY
Asia Pac J Clin Oncol; 2016 Dec; 12(4):396-402. PubMed ID: 27357443
[TBL] [Abstract][Full Text] [Related]
7. Diabetic Ketoacidosis and Acute Pancreatitis: Serious Adverse Effects of Everolimus.
Acharya GK; Hita AG; Yeung SJ; Yeung SJ
Ann Emerg Med; 2017 May; 69(5):666-667. PubMed ID: 28442095
[No Abstract] [Full Text] [Related]
8. Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs).
Vernieri C; Pusceddu S; Fucà G; Indelicato P; Centonze G; Castagnoli L; Ferrari E; Ajazi A; Pupa S; Casola S; Foiani M; Mazzaferro V; Pruneri G; Milione M; de Braud F
Int J Cancer; 2019 Apr; 144(7):1704-1712. PubMed ID: 30520016
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridemia triggered acute pancreatitis in pregnancy - diagnostic approach, management and follow-up care.
Cruciat G; Nemeti G; Goidescu I; Anitan S; Florian A
Lipids Health Dis; 2020 Jan; 19(1):2. PubMed ID: 31901241
[TBL] [Abstract][Full Text] [Related]
10. Safe and Effective Triglyceride-Lowering Therapy for Hypertriglyceridemia Associated Pancreatitis: Insulin Mono-therapy in a Non-Diabetic Patient.
Xie C; Stevens DC; Sturm T
S D Med; 2018 Jan; 71(1):26-28. PubMed ID: 29439301
[TBL] [Abstract][Full Text] [Related]
11. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia.
Goldenberg NM; Wang P; Glueck CJ
Clin Chim Acta; 2003 Jun; 332(1-2):11-9. PubMed ID: 12763274
[TBL] [Abstract][Full Text] [Related]
12. Hypertriglyceridemia-induced acute pancreatitis treated with insulin and heparin.
Twilla JD; Mancell J
Am J Health Syst Pharm; 2012 Feb; 69(3):213-6. PubMed ID: 22261942
[TBL] [Abstract][Full Text] [Related]
13. Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review.
Kuchay MS; Farooqui KJ; Bano T; Khandelwal M; Gill H; Mithal A
Arch Endocrinol Metab; 2017; 61(2):198-201. PubMed ID: 28225998
[TBL] [Abstract][Full Text] [Related]
14. Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study.
Sandhu S; Al-Sarraf A; Taraboanta C; Frohlich J; Francis GA
Lipids Health Dis; 2011 Sep; 10():157. PubMed ID: 21906399
[TBL] [Abstract][Full Text] [Related]
15. The effect of intravenous insulin, apheresis and oral lipid-lowering agents on non-fasting hypertriglyceridemia and associated pancreatitis.
Frankova D; Olson KM; Whyms BJ; Guevara Hernandez MA; Franko J
Postgrad Med; 2018 Jun; 130(5):494-500. PubMed ID: 29702000
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hypertriglyceridemia: plasma exchange].
Koike M; Nitta K
Nihon Rinsho; 2013 Sep; 71(9):1667-9. PubMed ID: 24205732
[TBL] [Abstract][Full Text] [Related]
17. An acute edematous pancreatitis case developed on the basis of hypertriglyceridemia.
Aslan T; Erden A; Karagoz H; Karahan S; Aykas F; Uslu E; Mutlu H; Karaman A
Med Arch; 2013; 67(4):295-6. PubMed ID: 24520759
[TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia-Induced Pancreatitis in Psychiatric Patients: A Case Report and Review of Literature.
Alastal Y; Hasan S; Chowdhury MA; Hammad T; Safi F; Rapport D; Assaly R
Am J Ther; 2016; 23(3):e947-9. PubMed ID: 24987947
[TBL] [Abstract][Full Text] [Related]
19. Hypertriglyceridemia and pancreatitis associated with estramustine phosphate.
Olson EL; Whang YE
Am J Clin Oncol; 2002 Aug; 25(4):342-3. PubMed ID: 12151961
[TBL] [Abstract][Full Text] [Related]
20. Commentary. Secondary causes of hypertriglyceridemia and pancreatitis.
Wagh A; Stone NJ
Clin Chim Acta; 2003 Jun; 332(1-2):21. PubMed ID: 12763275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
